Liquidity (Details Narrative) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Accumulated deficit | $ (121,370,240) | $ (65,698,101) |
Cash and cash equivalents | 41,748,468 | 62,537,495 |
Proceeds from sale of stock | 12,052,645 | $ 78,891,699 |
Kaken Pharmaceutical Co., Ltd. [Member] | ||
Upfront payment, recieved from related party | 27,000,000 | |
Cystic Fibrosis Foundation [Member] | Investment Agreement [Member] | ||
Proceeds from Royalty | $ 2,700,000 | |
Upfront payment, percentage | 10.00% | |
Cystic Fibrosis Foundation [Member] | Investment Agreement [Member] | January 2019 Offering [Member] | ||
Proceeds from sale of stock | $ 37,600,000 |
X | ||||||||||
- Definition Upfront payment, percentage. No definition available.
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Cash received for royalties during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|